Simplification Therapy with Once‐Daily Emtricitabine, Didanosine, and Efavirenz in HIV‐1–Infected Adults with Viral Suppression Receiving a Protease Inhibitor–Based Regimen: A Randomized TrialJean‐Michel Molina, Patrick Yéni, Willy Rozenbaum et al.|The Journal of Infectious Diseases|2005Cited by 68
Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD TrialsErkki Lathouwers, Renato Maserati, Eric Wong et al.|AIDS Research and Human Retroviruses|2019Cited by 14